List of works - Tomohiko Sadaoka

Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46.

scientific article published on May 2004

Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope

scientific article published on August 2004

Human herpesvirus 6 envelope cholesterol is required for virus entry

scientific article

Direct RNA sequencing on nanopore arrays redefines the transcriptional complexity of a viral pathogen

scientific article published in Nature Communications

Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts

scientific article

A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61.

scientific article published on 21 March 2018

Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread

scientific article

In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency.

scientific article published on 12 April 2016

Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease.

scientific article

Varicella-zoster virus ORF49 functions in the efficient production of progeny virus through its interaction with essential tegument protein ORF44

scientific article published on 23 October 2013

Molecular Aspects of Varicella-Zoster Virus Latency

scientific article published on 28 June 2018

Human herpesvirus 7 U47 gene products are glycoproteins expressed in virions and associate with glycoprotein H.

scientific article published on March 2006

Role of the JNK Pathway in Varicella-Zoster Virus Lytic Infection and Reactivation

scientific article published on 21 June 2017

Characterization of the varicella-zoster virus ORF50 gene, which encodes glycoprotein M.

scientific article

Varicella-zoster virus ORF1 gene product is a tail-anchored membrane protein localized to plasma membrane and trans-Golgi network in infected cells

scientific article published in August 2008

Characterization of the human herpesvirus 6A U23 gene

scientific article published on 22 December 2013

Human Embryonic Stem Cell-Derived Neurons Are Highly Permissive for Varicella-Zoster Virus Lytic Infection

scientific article published on 18 October 2017

Varicella-zoster virus glycoprotein M.

scientific article published on January 2010

Human herpesvirus-6 and human herpesvirus-7 (HHV-6, HHV-7)

scientific article published in December 2010

Vaccine Development for Varicella-Zoster Virus

article

Molecular Aspects of Varicella-Zoster Virus Latency

A unique, spliced varicella-zoster virus latency transcript represses expression of the viral transactivator gene 61

article

Decoding the Architecture of the Varicella-Zoster Virus Transcriptome

scientific article published on 06 October 2020

Decoding the architecture of the varicella-zoster virus transcriptome

scientific article published on 25 May 2020

List of works by Tomohiko Sadaoka

Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46.

Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope

Human herpesvirus 6 envelope cholesterol is required for virus entry

Direct RNA sequencing on nanopore arrays redefines the transcriptional complexity of a viral pathogen

Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts

A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61.

Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread

In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency.

Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease.

Varicella-zoster virus ORF49 functions in the efficient production of progeny virus through its interaction with essential tegument protein ORF44

Molecular Aspects of Varicella-Zoster Virus Latency

Human herpesvirus 7 U47 gene products are glycoproteins expressed in virions and associate with glycoprotein H.

Role of the JNK Pathway in Varicella-Zoster Virus Lytic Infection and Reactivation

Characterization of the varicella-zoster virus ORF50 gene, which encodes glycoprotein M.

Varicella-zoster virus ORF1 gene product is a tail-anchored membrane protein localized to plasma membrane and trans-Golgi network in infected cells

Characterization of the human herpesvirus 6A U23 gene

Human Embryonic Stem Cell-Derived Neurons Are Highly Permissive for Varicella-Zoster Virus Lytic Infection

Varicella-zoster virus glycoprotein M.

Human herpesvirus-6 and human herpesvirus-7 (HHV-6, HHV-7)

Vaccine Development for Varicella-Zoster Virus

Molecular Aspects of Varicella-Zoster Virus Latency

A unique, spliced varicella-zoster virus latency transcript represses expression of the viral transactivator gene 61

Decoding the Architecture of the Varicella-Zoster Virus Transcriptome

Decoding the architecture of the varicella-zoster virus transcriptome

Native RNA sequencing on nanopore arrays redefines the transcriptional complexity of a viral pathogen